Apyx Medical 2025 Q3 Earnings Beats Expectations with 64.3% Earnings Improvement

Apyx Medical (APYX) reported Q3 2025 earnings that exceeded expectations, . , reflecting strong demand for its AYON Body Contouring System and improved operational efficiency.

Revenue

, driven by the AYON launch, . , . The AYON system’s commercial success and higher-margin single-use handpieces propelled the Surgical Aesthetics segment’s performance.

Earnings/Net Income

, . , . , signaling positive progress despite ongoing losses.

Post-Earnings Price Action Review

, . This suggests short-term investor optimism, though past performance does not guarantee future results.

CEO Commentary

CEO highlighted AYON’s 19% Surgical Aesthetics revenue growth and plans to expand its user base. He emphasized pending for power liposuction as a key growth driver, positioning AYON to become the segment’s gold standard.

Guidance

, . , reflecting disciplined cost management and AYON-driven demand.

Additional News

Recent developments include the rebranding of the Advanced Energy segment to Surgical Aesthetics, aligning with the company’s strategic focus on body contouring solutions. A 510(k) submission for AYON’s power liposuction functionality aims to enhance its market position by Q1 2026. Additionally, Apyx’s plans, targeting Europe, the Middle East, and Brazil, underscore its ambition to capitalize on global demand for aesthetic procedures.

Backtest Anchor

The strategy of buying Apyx Medical (APYX) shares on the date of its revenue raise announcement and holding for 30 days showed favorable performance over the past three years. . After 30 days, , . Meanwhile, the overall market, as measured by the NASDAQ Composite Index, , indicating that the strategy outperformed the market. This result suggests that investors who followed this strategy would have achieved positive returns, with the stock price appreciating more than the broader market index. However, it's important to note that past performance is not always indicative of future results, and investors should consider other factors and consult with financial advisors before making investment decisions.